Allurion Technologies Inc. (ALUR)
NYSE: ALUR · Real-Time Price · USD
5.35
-0.37 (-6.47%)
Jan 30, 2025, 4:00 PM EST - Market closed
Allurion Technologies Revenue
Allurion Technologies had revenue of $5.37M in the quarter ending September 30, 2024, a decrease of -70.51%. This brings the company's revenue in the last twelve months to $34.75M, down -46.05% year-over-year. In the year 2023, Allurion Technologies had annual revenue of $53.47M, down -16.73%.
Revenue (ttm)
$34.75M
Revenue Growth
-46.05%
P/S Ratio
0.34
Revenue / Employee
$68,956
Employees
504
Market Cap
18.37M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 53.47M | -10.74M | -16.73% |
Dec 31, 2022 | 64.21M | 25.97M | 67.91% |
Dec 31, 2021 | 38.24M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionALUR News
- 6 days ago - Allurion Technologies Shares Are Up Today: What's Going On? - Benzinga
- 6 days ago - Allurion Stock Triples on Plan to Test Gastric Balloon With Obesity Drugs - Investopedia
- 6 days ago - Allurion to Raise Approximately $7.4 Million of Gross Proceeds in Offering Priced At-the-Market - Business Wire
- 7 days ago - Allurion Announces Plans To Optimize Muscle Mass During GLP-1 Therapy In Combination With the Allurion Program - Business Wire
- 9 days ago - Allurion Announces Notification of Issuance of New U.S. Patent on Next-Generation Weight Loss Device for the Treatment of Obesity - Business Wire
- 16 days ago - Allurion Announces Private Placement of Common Stock and Preliminary Unaudited Financial Results for the Fourth Quarter and Fiscal Year 2024 - Business Wire
- 22 days ago - Allurion Announces Positive Topline Results From AUDACITY Trial - Business Wire
- 5 weeks ago - Allurion Technologies, Inc. Announces Reverse Stock Split - Business Wire